Ask AI
ProCE Banner Activity

Multimodal CE Improves Knowledge and Clinical Skills in Atopic Dermatitis

PDF

Explore outcomes from a multimodal continuing education program on advanced biologic therapies for moderate to severe atopic dermatitis, including learner knowledge and clinical skills, intended practice changes, and barriers to implementation among US healthcare professionals.

Released: November 02, 2026

Share

Target Audience

This activity is intended for dermatologists, allergist/immunologists, nurse practitioners, and physician associates practicing in dermatology who manage patients with moderate to severe atopic dermatitis.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate therapeutic response in adults with moderate to severe atopic dermatitis who are receiving biologic therapy

  • Classify adults with moderate to severe atopic dermatitis who qualify for IL-13–targeted biologic therapy

  • Appraise clinical evidence for advanced biologic therapies in moderate to severe atopic dermatitis

Additional Disclosures

Generative artificial intelligence (AI) tools were used for data analysis or summarization influencing content. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.